Brown, Lisle/Cummings’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$217K Buy
2,098
+287
+16% +$32.5K 0.05% 203
2025
Q4
$183K Hold
1,811
0.05% 219
2025
Q3
$223K Sell
1,811
-325
-15% -$40.3K 0.06% 202
2025
Q2
$256K Buy
2,136
+89
+4% +$11.9K 0.07% 191
2025
Q1
$301K Buy
2,047
+9
+0.4% +$1.37K 0.09% 179
2024
Q4
$331K Hold
2,038
0.1% 175
2024
Q3
$332K Hold
2,038
0.1% 172
2024
Q2
$278K Hold
2,038
0.09% 177
2024
Q1
$312K Hold
2,038
0.11% 165
2023
Q4
$291K Hold
2,038
0.11% 170
2023
Q3
$267K Buy
2,038
+800
+65% +$122K 0.12% 154
2023
Q2
$197K Buy
1,238
+800
+183% +$129K 0.09% 180
2023
Q1
$69.3K Hold
438
0.04% 248
2022
Q4
$61.5K Hold
438
0.03% 249
2022
Q3
$56.2K Hold
438
0.03% 246
2022
Q2
$61.7K Hold
438
0.03% 238
2022
Q1
$60.9K Hold
438
0.03% 248
2021
Q4
$76.4K Buy
+438
New +$73K 0.04% 230

Other funds holding CLX

Brown, Lisle/Cummings's CLX Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Clorox (CLX) stake by 16% in Q1 2026, buying an estimated $32.5K and bringing the position to 2,098 shares worth $217K. The position accounts for 0.05% of the portfolio, ranked #203.

Brown, Lisle/Cummings first reported a position in CLX in Q4 2021 and has held it in 18 quarters since. The position peaked at $332K in Q3 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Brown, Lisle/Cummings held 2,098 shares of Clorox worth $217K as of Q1 2026.
  • Brown, Lisle/Cummings bought 287 Clorox shares in Q1 2026, an estimated $32.5K.
  • Clorox made up 0.05% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #203 holding.
  • Brown, Lisle/Cummings first reported a position in Clorox in Q4 2021 and has held it in 18 quarters since.
  • Brown, Lisle/Cummings's Clorox position peaked at $332K in Q3 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.